Top NewsBusinessTechHealthLifestyleReal EstateHealth Biotech, pharma, medical devices and FDA news.News provided by PR NewswireAntengene Receives Clinical Trial Approval in Australia for Phase I ATTRACT Study of ATG-201 (CD19 x CD3 TCE) in B Cell-related Autoimmune DiseasesANTENGENE CORPORATION LIMITED, 5 hours agoAstellas Doses First Patient in Phase 3 Study of ASP2138 in CLDN18.2-postive and HER2-negative locally advanced unresectable or metastatic gastric or gastroesophageal junction (GEJ) adenocarcinomaASTELLAS PHARMA INC., 6 hours agoFDA approves IMAAVY® (nipocalimab-aahu) as first-ever treatment for warm autoimmune hemolytic anemia (wAIHA), representing a landmark advancement for patientsJOHNSON & JOHNSON, 6 hours agoTGH Brooksville Performs First Cardiothoracic Surgery, Expanding Access to Advanced Heart Care in Hernando CountyTAMPA GENERAL HOSPITAL, 9 hours ago
Antengene Receives Clinical Trial Approval in Australia for Phase I ATTRACT Study of ATG-201 (CD19 x CD3 TCE) in B Cell-related Autoimmune DiseasesANTENGENE CORPORATION LIMITED, 5 hours ago
Astellas Doses First Patient in Phase 3 Study of ASP2138 in CLDN18.2-postive and HER2-negative locally advanced unresectable or metastatic gastric or gastroesophageal junction (GEJ) adenocarcinomaASTELLAS PHARMA INC., 6 hours ago
FDA approves IMAAVY® (nipocalimab-aahu) as first-ever treatment for warm autoimmune hemolytic anemia (wAIHA), representing a landmark advancement for patientsJOHNSON & JOHNSON, 6 hours ago
TGH Brooksville Performs First Cardiothoracic Surgery, Expanding Access to Advanced Heart Care in Hernando CountyTAMPA GENERAL HOSPITAL, 9 hours ago
